Active substanceTaurineTaurine
Similar drugsTo uncover
  • Dibicor®
    pills inwards 
    PIK-PHARMA, LLC     Russia
  • Dibicor®
    pills inwards 
    PIK-PHARMA, LLC     Russia
  • Igrele®
    drops d / eye 
    KVADRAT-S, LLC     Russia
  • CardioActiv® Taurine
    pills inwards 
    EVALAR, CJSC     Russia
  • Taurine
    drops d / eye 
  • Taurine
    drops d / eye 
    UPDATE OF PFC, CJSC     Russia
  • Taurine
    drops d / eye 
    VIFITEH, CJSC     Russia
  • Taurine
    solution
    DALHIMFARM, OJSC     Russia
  • Taurine
    drops d / eye 
  • Taurine
    drops d / eye 
    Firm VIPS-MED, LLC     Russia
  • Taurine
    films d / eye 
    Progress RCC, JSC     Russia
  • Taurine
    drops d / eye 
  • Taurine
    drops d / eye 
    Company DEKO, LLC     Russia
  • Taurine
    drops d / eye 
  • Taurin-Akos
    drops d / eye 
    SYNTHESIS, OJSC     Russia
  • Taurin-DIA
    drops d / eye 
  • Taurin-SOLOFARM
    drops d / eye 
    GROTEKS, LLC     Russia
  • Taufon
    drops d / eye 
  • Dosage form: & nbspeye drops
    Composition:

    active substance - taurine (taufon) - 40 mg / ml

    Excipients - metnlparahydroxyboisoate, purified water.

    Description:colorless transparent liquid.
    Pharmacotherapeutic group:metabolic means.
    ATX: & nbsp

    S.01.X.A   Other drugs for the treatment of eye diseases

    C.01.E.B   Other drugs for the treatment of heart disease

    Pharmacodynamics:

    Taurine is a sulfur-containing amino acid that forms in the body during the conversion of cysteine. The drug contributes to the improvement of energy processes, stimulates reparative processes in diseases of a dystrophic nature and processes accompanied by a sharp disruption of the metabolism of the eye tissues. As a sulfur-containing amino acid the drug contributes to the normalization of the function of cell membranes, the improvement of energy and metabolic processes.

    Pharmacokinetics:With topical application, systemic absorption is low.
    Indications:

    The drug is prescribed for adults with corneal dystrophy, senile, traumatic, radiation and other types of cataracts, as well as with corneal injuries (as a stimulant of reparative processes).

    Contraindications:Hypersensitivity to taurine, children's age (under 18 years), pregnancy and period of feeding piles.
    Dosing and Administration:

    When cataracts are prescribed in the form of instillations 1-2 drops 2-4 times a day for 3 months. The course is repeated at a monthly interval.In injuries and dystrophic diseases, corneas are used in the same doses for one month.

    Side effects:Allergic reactions.
    Interaction:
    Form release / dosage:

    Eye drops 4 %

    5 or 10 ml in the glass bottles. Each glass bottle with a lid - a drop of a glass (or without it) with instructions for use - in a pack of cardboard.

    For 5 or 10 ml in the bottles-droppers are polyethylene or polypropylene. Each polyethylene or polypropylene bottle with instructions for use - in a pack of cardboard.

    Packaging:eye drops, 4% (bottle) 5/10 ml x 1 (carton pack); [eye drops, 4% (vial) 5/10 ml x 1 + (cap-dropper) x 1] x 1 (cardboard pack); eye drops, 4% (flask-dropper) 5/10 ml x 1 (pack of cardboard)
    Storage conditions:List B. Store at a temperature of no higher than 25 ° C in a dark place. Keep out of the reach of children.
    Shelf life:

    4 years in a glass bottle and 3 years in a polyethylene or polypropylene flask-dropper.

    Do not use after the expiry date printed on the package.

    The opened vial should not be stored for more than 30 days.

    Terms of leave from pharmacies:On prescription
    Registration number:P N002696 / 01
    Date of registration:14.08.2008
    The owner of the registration certificate:Pharmaceutical firm LEKKO, ZAO Pharmaceutical firm LEKKO, ZAO Russia
    Manufacturer: & nbsp
    Information update date: & nbsp05.09.2015
    Illustrated instructions
      Instructions
      Up